Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure

European Journal of Heart Failure

Volumn 6, Issue 1, 2004, Pages 85-93

  Whalley, Gillian A ^a   Gamble, Greg D ^a   Walsh, Helen J ^a   Wright, Susan P ^a   Agewall, Stefan ^b   Sharpe, Norman ^a   Doughty, Robert N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contrast; Echocardiography; Ejection fraction; Harmonics; Heart failure; Reproducibility

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE VOLUME; HUMAN; INTERMETHOD COMPARISON; MALE; MITRAL VALVE; PRIORITY JOURNAL; REPRODUCIBILITY;

CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ENDOCARDIUM; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; OBSERVER VARIATION; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED; STROKE VOLUME;

EID: 0842304868     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.09.011     Document Type: Article

References (55)

1. Cheeseman M., Leech G., Chambers J., Monaghan M., Nihoyannopoulos P. Central role of echocardiography in the diagnosis and assessment of heart failure. Heart. 80:1998;S1-S5.
2. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Website 2001.
3. White H.D., Norris R.M., Brown M.A., Brandt P.W.T., Whitlock R.M.L., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51.
4. Cohn J.N., Rector T.S. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 62:1988;25A-30A.
5. Gradman A., Deedwania P., Cody R., et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 14:1989;564-570.
6. Harjaj K.J., Nunez E., Turgut T., et al. The independent effects of left ventricular ejection fraction on short-term outcomes and resource utilization following hospitalization for heart failure. Clin Cardiol. 22:1999;184-190.
7. Cintron G., Johnson G., Francis G., Cobb F., Cohn J.N. For the V-HeFT VA Cooperative Studies Group. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. Circulation. 87:(Suppl VI):1993;VI-17-VI-23.
8. Parameshwar J., Shackell M.M., Richardson A., Poole-Wilson P.A., Sutton G.C. Prevalence of heart failure in three general practices in north west London. Br J Gen Pract. 42:1992;287-289.
9. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988:1988;255-259.
10. Pfeffer M.A., Braunwald E., Moye L.A., et al. On behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 327:1992;669-677.
11. Doughty R.N., Whalley G.A., Gamble G., MacMahon S., Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol. 29:1997;1060-1066.
12. Cohn J., Ferrari R., Sharpe N. On behalf of an International Forum on Cardiac Remodeling. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 35:2000;569-582.
13. StJohn Sutton M., Sharpe N. Left ventricular remodelling after myocardial infarction. Circulation. 101:2000;2981-2988.
14. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 90:2002;29-34.
15. McGowan J.H., Cleland J.G.F. The reliability of reporting left ventricular systolic function by echocardiography: a systematic review of three methods. Am Heart Journal. 146:2003;388-397.
16. Mulvagh S.L., DeMaria A.N., Feinstein S.B., et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr. 13:2000;331-342.
17. Caidahl K., Kazzam E., Lidberg J., et al. New concept in echocardiography: harmonic imaging of tissue without use of contrast agent. Lancet. 352:1998;1264-1270.
18. Nixdorff U., Matschke C., Winklmaier M., et al. Native tissue harmonic imaging improves endocardial and epicardial border definition in dobutamine stress echocardiography. Eur J Echocardiogr. 2:2001;52-61.
19. Van Camp G., Franken R.R., Schoors D., et al. Impact of tissue harmonic imaging on the determination of the global and regional left ventricular function by 2D echocardiography: a comparison with MIBI gated SPECT. Eur J Echocardiogr. 1:2000;122-129.
20. Feinstein S.B., Cheirif J., Ten Cate F.J., et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol. 16:1990;316-324.
21. Cohen J.L., Cheirif J., Segar D.S., et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol. 32:1998;746-752.
22. Grayburn P.A., Weiss J.L., Hack T.C., et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol. 32:1998;230-236.
23. Kitzman D., Goldman D., Hack T., Gillam L., Fenster P., Segar D. Efficacy of DMP-115 contrast for left ventricular evaluation in patients with suboptimal baseline images: a multicentre, double blind, randomized, placebo controlled trial [abstract]. J Am Soc Echocardiogr. 11:1998;555.
24. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., Grayburn P.A. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol. 32:1998;1426-1432.
25. Thomson H.L., Basmadjian A., Rainbird A.J., et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements. J Am Coll Cardiol. 38:2001;867-875.
26. Nahar T., Croft L., Shapiro R., et al. Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction. Am J Cardiol. 86:2000;1358-1362.
27. Becher H., Burns P.N. Handbook of contrast echocardiography. 1st ed:2000;Springer, Berlin.
28. Kornbluth M., Liang D.H., Paloma A., Schnittger I. Native tissue harmonic imaging improves endocardial border definition and visualisation of cardiac structures. J Am Soc Echocardiogr. 11:1998;693-701.
29. Mulvagh S.L., Foley D.A., Belohlavek M., Seward J.B. Image enhancement by noncontrast harmonic echocardiography. Part 1. Qualitative assessment of endocardial visualisation. Mayo Clin Proc. 73:1998;1062-1065.
30. Spencer K., Bednarz J., Rafter P., Korcarz C., Lang R. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol. 82:1998;794-799.
31. Belohlavek M., Tanabe K., Mulvagh S.L., Foley D.A., Greenleaf J.F., Seward J.B. Image enhancement by noncontrast harmonic echocardiography. Part II. Quantitative assessment with use of contrast-to-speckle ratio. Mayo Clin Proc. 73:1998;1066-1070.
32. Skolnick D.G., Sawada S.G., Feigenbaum H., Segar D.S. Enhanced endocardial visualisation with noncontrast harmonic imaging during stress echocardiography. J Am Soc Echocardiogr. 12:1999;559-563.
33. Senior R., Soman P., Khattar R.S., Lahiri A. Improved endocardial visualisation with tissue harmonic imaging compared with fundamental two-dimensional echocardiographic imaging. Am Heart J. 138:1999;163-168.
34. Rubin D.N., Yazbek N., Garcia M.J., Stewart W.J., Thomas J.D. Qualitative and quantitative effects of harmonic echocardiographic imaging on endocardial edge definition and side-lobe artifacts. J Am Soc Echocardiogr. 13:2000;1012-1018.
35. Franke A., Hoffman R., Kuhl H.P., et al. Non-contrast tissue harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality. Heart. 83:2000;133-140.
36. Yu E.H., Sloggett C.E., Iwanochko R.M., Rakowski H., Siu S.C. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients. J Am Soc Echocardiogr. 13:2000;216-224.
37. Crouse L.J., Cherif J., Hanly D.E., et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol. 22:1993;1494-1500.
38. Schröder K., Agrawal R., Völler H., Schlief R., Schröder R. Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SH U 508 A. Int J Cardiac Imaging. 10:1994;45-51.
39. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., Grayburn P.A. Effect of contrast enhancement on transthoracic echocardiographic assessment of left ventricular regional wall motion. Am J Cardiol. 84:1999;1365-1368. A8-A9.
40. Kitzman D.W., Goldman M.E., Gillam L.D., Cohen J.L., Aurigemma G.P., Gottdiener J.S. Efficacy and safety of the novel ultrasound contrast agent Perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol. 86:2000;669-674.
41. Weissman N.J., Cohen M.C., Hack T.C., Gillam L.D., Cohen J.L., Kitzman D.W. Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial. Am Heart J. 139:2000;399-404.
42. Main M.L., Asher C.R., Rubin D.N., et al. Comparison of tissue harmonic imaging with contrast (sonicated albumin) echocardiography and Doppler myocardial imaging for enhancing endocardial border resolution. Am J Cardiol. 83:1999;218-222.
43. Kasprzak J.D., Paelinck B., Ten Cate F.J., et al. Comparison of native and contrast-enhanced harmonic echocardiography for visualisation of left ventricular endocardial border. Am J Cardiol. 83:1999;211-217.
44. Reilly J.P., Tunick P.A., Timmermans R.J., Stein B., Rosenzweig B.P., Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol. 35:2000;485-490.
45. Kornbluth M., Liang D.H., Brown P., Gessford E., Schnittger I. Contrast echocardiography is superior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients. Am Heart J. 140:2000;246-291.
46. Nguyen T.T., Dhond M.R., Sabapathy R., Bommer W.J. Contrast microbubbles improve diagnostic yield in ICU patients with poor echocardiographic windows. Chest. 120:2001;1287-1292.
47. Yong Y., Wu D., Fernandes V., et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol. 89:2002;711-718.
48. Gandhok N.K., Block R., Ostoic T., et al. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex. J Am Soc Echocardiogr. 10:1997;25-30.
49. Uchimoto R., Niwa K., Tsuda N., Miyazawa T., Bräutigam M. Comparison of the efficacy of two air-based contrast agents in dogs. Eur J Ultrasound. 11:2000;127-133.
50. Sapin P.M., Schroder K.M., Gopal A.S., Smith M.D., DeMaria A.N., King D.L. Comparison of two- and three-dimensional echocardiography with cineventriculography for measurement of left ventricular volume in patients. J Am Coll Cardiol. 24:1994;1054-1063.
51. Lafitte S., Dos Santos P., Kerouani A., Robhan T., Roudaut R. Improved reliability for echocardiographic measurement of left ventricular volume using harmonic power imaging mode combined with contrast agent. Am J Cardiol. 85:2000;1234-1238.
52. Chuang M.L., Hibberd M.G., Salton C.J., et al. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol. 35:2000;477-484.
53. Himelman R.B., Cassidy M.M., Landzberg J.S., Schiller N.B. Reproducibility of quantitative two-dimensional echocardiography. Am Heart J. 115:1988;425-431.
54. Senior R., Sridhara B.S., Basu S., et al. Comparison of radionuclide ventriculography and 2D echocardiography for the measurement of left ventricular ejection fraction following acute myocardial infarction. Eur Heart J. 15:1994;1235-1239.
55. Otterstad J.E., Froeland G., StJohn Sutton M., Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J. 18:1997;507-513.